FIELD: medicine, in particular dry azithromicine mixtures to produce azithromicine pellets by direct pressing.
SUBSTANCE: claimed formulation contains non-dehydrated azithromicine selected from group containing B, D, E, F, G, H, J, M, N, O, P, Q, R forms or mixtures thereof, and at least one pharmaceutically acceptable carrier. Pellet containing non-dehydrated azithromicine mixture and at least one pharmaceutically acceptable carrier, as well as azithromicine pellet obtained by providing of dry mixture containing non-granulated azithromicine A and at least one pharmaceutically acceptable carrier, followed by direct pressing said mixture also are disclosed.
EFFECT: direct pressable azithromicine-containing formulations; azithromicine pellets having acceptable hardness and frangibility.
14 cl, 6 ex, 1 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR AZITROMICINE WET GRANULATION | 2002 |
|
RU2283651C2 |
| DRY GRANULATED AZITHROMICINE COMPOSITIONS | 2003 |
|
RU2283092C2 |
| INTEGRATED INTO TABLETS LIQUID LUBRICANTS FOR TABLETTING | 2008 |
|
RU2473243C2 |
| HIGH-COMPRESSIBLE ETHYL CELLULOSE FOR TABLETTING | 2002 |
|
RU2396072C2 |
| SOLID PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 1995 |
|
RU2152802C2 |
| SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING COMBINATION OF VILDAGLIPTIN AND GLIQUIDONE | 2014 |
|
RU2585378C1 |
| CLOZAPINE TABLETS WITH DELAYED RELEASE AND METHOD OF OBTAINING THEREOF | 2015 |
|
RU2624229C2 |
| ORALLY DISINTEGRATING TABLET TEMAZEPAM COMPOSITIONS | 2008 |
|
RU2524638C2 |
| METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION BASED ON HEXAMETHYLENEDIAMIDE BIS-(N-MONOSUCINYL-L-SERYL-L-LYSINE) | 2021 |
|
RU2790827C1 |
| DRUG FORMS OF IRON (III) CITRATE | 2010 |
|
RU2563819C2 |
